6 papers
Evaluating 5G-connected IoT for Power Line Temperature Prediction: Real-World Latency and Cost Trade-offs Between MEC and Cloud
Aakash Sharma, Sigmund Akselsen, Anders Andersen +2
One of the key promises of Mobile Edge Computing (MEC) is its low latency. Current large-scale IoT deployments rely on cloud for their reliability, low cost, and ease of use. For o…
From research to clinic: Accelerating the translation of clinical decision support systems by making synthetic data interoperable
Pavitra Chauhan, Mohsen Gamal Saad Askar, Kristian Svendsen +4
The translation of clinical decision support system (CDSS) tools from research settings into the clinic is often non-existent, partly because the focus tends to be on training mach…
Automating tumor-infiltrating lymphocyte assessment in breast cancer histopathology images using QuPath: a transparent and accessible machine learning pipeline
Masoud Tafavvoghi, Lars Ailo Bongo, André Berli Delgado +5
In this study, we built an end-to-end tumor-infiltrating lymphocytes (TILs) assessment pipeline within QuPath, demonstrating the potential of easily accessible tools to perform com…
A Lightweight and Extensible Cell Segmentation and Classification Model for Whole Slide Images
Nikita Shvetsov, Thomas K. Kilvaer, Masoud Tafavvoghi +4
Developing clinically useful cell-level analysis tools in digital pathology remains challenging due to limitations in dataset granularity, inconsistent annotations, high computatio…
Open-source framework for detecting bias and overfitting for large pathology images
Anders Sildnes, Nikita Shvetsov, Masoud Tafavvoghi +5
Even foundational models that are trained on datasets with billions of data samples may develop shortcuts that lead to overfitting and bias. Shortcuts are non-relevant patterns in…
Fast TILs -- A Pipeline for Efficient TILs Estimation in Non-Small Cell Lung Cancer
Nikita Shvetsov, Anders Sildnes, Masoud Tafavvoghi +5
Addressing the critical need for accurate prognostic biomarkers in cancer treatment, quantifying tumor-infiltrating lymphocytes (TILs) in non-small cell lung cancer (NSCLC) present…